Oestrogen-related receptor alpha inverse agonist XCT-790 arrests A549 lung cancer cell population growth by inducing mitochondrial reactive oxygen species production

Cell Proliferation

Volumn 43, Issue 2, 2010, Pages 103-113

  Wang, J ^a   Wang, Y ^a   Wong, C ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; ESTROGEN RELATED RECEPTOR ALPHA; HORMONE RECEPTOR STIMULATING AGENT; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; XCT 790;

ARTICLE; CELL CYCLE ARREST; CELL DIVISION; CELL GROWTH; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BENZIMIDAZOLES; CARBOCYANINES; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; HUMANS; LUNG; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE POTENTIALS; MITOCHONDRIA; NITRILES; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; THIAZOLES; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77649216353     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00659.x     Document Type: Article

References (47)

1. Giguere V (1999) Orphan nuclear receptors: from gene to function. Endocr. Rev. 20, 689 725.
2. Tremblay GB, Kunath T, Bergeron D, Lapointe L, Champigny C, Bader J-A et al. (2001) Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR{beta}. Genes Dev. 15, 833 838.
3. Yang C, Chen S (1999) Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor {{alpha}}-1 orphan receptor. Cancer Res. 59, 4519 4524.
4. Busch BB, Stevens WC Jr., Martin R, Ordentlich P, Zhou S, Sapp DW et al. (2004) Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha. J. Med. Chem. 47, 5593 5596.
5. Chisamore MJ, Mosley RT, Cai S-J, Birzin ET, O'Donnell G, Zuck P et al. (2008) Identification of small molecule estrogen-related receptor alpha-specific antagonists and homology modeling to predict the molecular determinants as the basis for selectivity over ERRbeta and ERRgamma. Drug Dev. Res. 69, 203 218.
6. Wang J, Fang F, Huang Z, Wang Y, Wong C (2009) Kaempferol is an estrogen-related receptor [alpha] and [gamma] inverse agonist. FEBS Lett. 583, 643 647.
7. Christoph H, Rhee J, Lin J, Tarr PT, Spiegelman BM (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle. Proc. Natl. Acad. Sci. USA 100, 7111 7116.
8. Huss JM, Torra IP, Staels B, Giguere V, Kelly DP (2004) Estrogen-related receptor {alpha} directs peroxisome proliferator-activated receptor {alpha} signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 24, 9079 9091.
9. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S et al. (2004) Err{alpha} and Gabpa/b specify PGC-1{alpha}-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. USA 101, 6570 6575.
10. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M et al. (2004) The estrogen-related receptor {alpha} (ERR{alpha}) functions in PPAR{gamma} coactivator 1{alpha} (PGC-1{alpha})-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. USA 101, 6472 6477.
11. Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H et al. (2004) Estrogen-related receptor {alpha} in human breast carcinoma as a potent prognostic factor. Cancer Res. 64, 4670 4676.
12. Sun P, Sehouli J, Denkert C, Mustea A, Könsgen D, Koch I et al. (2005) Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. J. Mol. Med. 83, 457 467.
13. Cheung CP, Yu S, Wong KB, Chan LW, Lai FM, Wang X et al. (2005) Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J. Clin. Endocrinol. Metab. 90, 1830 1844.
14. Cavallini A, Notarnicola M, Giannini R, Montemurro S, Lorusso D, Visconti A et al. (2005) Oestrogen receptor-related receptor alpha (ERR[alpha]) and oestrogen receptors (ER[alpha] and ER[beta]) exhibit different gene expression in human colorectal tumour progression. Eur. J. Cancer 41, 1487 1494.
15. Ariazi EA, Clark GM, Mertz JE (2002) Estrogen-related receptor {alpha} and estrogen-related receptor {gamma} associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res. 62, 6510 6518.
16. Stein RA, Chang C-Y, Kazmin DA, Way J, Schroeder T, Wergin M et al. (2008) Estrogen-related receptor {alpha} is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res. 68, 8805 8812.
17. Lanvin O, Bianco S, Kersual N, Chalbos D, Vanacker J-M (2007) Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-{alpha} degradation by the estrogen receptor-related receptor-{alpha} inverse agonist XCT790. J. Biol. Chem. 282, 28328 28334.
18. Chisamore MJ, Wilkinson HA, Flores O, Chen JD (2009) Estrogen-related receptor-{alpha} antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Mol. Cancer Ther. 8, 672 681.
19. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M et al. (2007) Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERR[alpha] and [gamma]. Cell Metab. 5, 345 356.
20. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED (2005) Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112, 2686 2695.
21. Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A (2003) The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278, 9013 9018.
22. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y et al. (2007) The transcriptional coactivator PGC-1[beta] drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35 46.
23. Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, Wang F et al. (2006) Estrogen related receptors stimulate pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression. J. Biol. Chem. 281, 39897 39906.
24. Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP (2005) PGC-1{alpha} coactivates PDK4 gene expression via the orphan nuclear receptor ERR{alpha}: a mechanism for transcriptional control of muscle glucose metabolism. Mol. Cell. Biol. 25, 10684 10694.
25. Rangwala SM, Li X, Lindsley L, Wang X, Shaughnessy S, Daniels TG et al. (2007) Estrogen-related receptor [alpha] is essential for the expression of antioxidant protection genes and mitochondrial function. Biochem. Biophys. Res. Commun. 357, 231 236.
26. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397 408.
27. Rousset S, Alves-Guerra M-C, Mozo J, Miroux B, Cassard-Doulcier A-M, Bouillaud F et al. (2004) The biology of mitochondrial uncoupling proteins. Diabetes 53, S130 S135.
28. Buschmann T, Potapova O, Bar-Shira A, Ivanov VN, Fuchs SY, Henderson S et al. (2001) Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21, 2743 2754.
29. Yamaguchi T, Miki Y, Yoshida K (2007) Protein kinase C [delta] activates I[kappa]B-kinase [alpha] to induce the p53 tumor suppressor in response to oxidative stress. Cell. Signal. 19, 2088 2097.
30. Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F (2008) E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines. Oncogene. 27, 5303 5314.
31. Ohtani K, DeGregori J, Nevins JR (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92, 12146 12150.
32. Blais A, Monte D, Pouliot F, Labrie C (2002) Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. J. Biol. Chem. 277, 31679 31693.
33. Opavsky R, Tsai SY, Guimond M, Arora A, Opavska J, Becknell B et al. (2007) Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc. Natl. Acad. Sci. USA 104, 15400 15405.
34. Kraus RJ, Ariazi EA, Farrell ML, Mertz JE (2002) Estrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. J. Biol. Chem. 277, 24826 24834.
35. Krishnan A, Nair SA, Pillai MR (2007) Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr. Mol. Med. 7, 532 540.
36. Wang Y, Kreisberg JI, Ghosh PM (2007) Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer. Curr. Cancer Drug Targets 7, 591 604. (Pubitemid 47358145)
37. Jordan VC (2007) Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat. Rev. Cancer 7, 46 53.
38. Hodgson MC, Astapova I, Hollenberg AN, Balk SP (2007) Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res. 67, 8388 8395.
39. Rouanet P, Linares-Cruz G, Dravet F, Poujol S, Gourgou S, Simony-Lafontaine J et al. (2005) Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen. J. Clin. Oncol. 23, 2980 2987.
40. Mossner R, Schulz U, Kruger U, Middel P, Schinner S, Fuzesi L et al. (2002) Agonists of peroxisome proliferator-activated receptor [ggr] inhibit cell growth in malignant melanoma. J. Invest. Dermatol. 119, 576 582.
41. Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG (2005) Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. J. Cell. Biochem. 96, 760 774.
42. Egerod FL, Nielsen HS, Iversen L, Thorup I, Storgaard T, Oleksiewicz MB (2005) Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo. Biomarkers 10, 295 309. (Pubitemid 41448390)
43. Lu D, Kiriyama Y, Lee KY, Giguere V (2001) Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res. 61, 6755 6761.
44. Yaohui Nie CW (2008) Suppressing the activity of ERRalpha in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal glucose uptake. J. Cell. Mol. Med. DOI:10.1111/j.1582-4934.2008.00382.X.
45. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H et al. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by [beta]-phenylethyl isothiocyanate. Cancer Cell 10, 241 252.
46. Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M (2007) Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2, e693.
47. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 100, 8466 8471.